Abstract
Stereotactic body radiation therapy (SBRT) is an increasingly common treatment for lung and liver malignancies. Chest wall toxicity following SBRT for peripheral tumors has been reported and there are published dose constraint guidelines to minimize the risk for rib fracture, chest wall necrosis, and cutaneous ulceration.1-4 There are no documented reports of diaphragm injury after SBRT and no defined tolerance dose. We describe in this report the clinical course of a patient who developed severe back pain following liver SBRT and was found to have focal necrosis, fibrosis, and atrophy of the diaphragm in the high-dose region on autopsy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
